Carbamazepine-induced angioedema
- PMID: 27999472
- PMCID: PMC5153889
- DOI: 10.4103/0976-0105.189436
Carbamazepine-induced angioedema
Abstract
Angioedema is a rare adverse reaction of carbamazepine, which causes localized tissue edema in submucosal and subcutaneous tissue mediated by histamine, serotonin, and kinins (bradykinin). We report a case of 34-year-old female who developed angioedema, 24 h after administration of carbamazepine for treating bipolar disorder. Patient's symptoms responded rapidly with antihistamine therapy and with the withdrawal of carbamazepine, the offending drug. Carbamazepine-induced angioedema is a life-threatening reaction which requires immediate treatment and monitoring in order to avoid morbidity and mortality.
Keywords: Angioedema; antiepileptic drug; carbamazepine; cutaneous reaction.
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Elias A, Madhusoodanan S, Pudukkadan D, Antony JT. Angioedema and maculopapular eruptions associated with carbamazepine administration. CNS Spectr. 2006;11:352–4. - PubMed
-
- Gupta SN, Gupta VS. Angioedema caused by carbamazepine or acetazolamide: A single drug solution – An illustrative case report. Neurol Open J. 2014;1:20–2.
-
- Inomata N. Recent advances in drug-induced angioedema. Allergol Int. 2012;61:545–57. - PubMed